Director/PDMR Shareholding

RNS Number : 3231D
Medaphor Group PLC
09 October 2018
 

9 October 2018

MedaPhor Group plc

 

(the "Group", or the "Company")

 

Director/PDMR Shareholding

 

Further to the announcement made on 8 October 2018, MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that Andrew Barker, Non-Executive Director of the Company, has been issued 66,781 new ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") pursuant to the completion of the acquisition of Intelligent Ultrasound Limited, which was originally announced on 19 September 2017.

 

Following this issue, Mr. Barker has an interest in 200,344 Ordinary Shares representing approximately 0.2 per cent. of the Company's issued ordinary share capital.

 

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Andrew Barker

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MEDAPHOR GROUP PLC

b)

 

LEI

 

 

213800K4ZVWL4ZYQAZ70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 1 pence each

 

 

ISIN: GB00BN791Q39

 

 

 

 

b)

 

Nature of the transaction

 

 

Issue of new Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil pence per share

66,781

 

 

d)

 

Aggregated information

- Aggregated volume

 

 

- Price

 

 

 

N/A - single transaction

 

 

 

e)

 

Date of the transaction

 

 

9 October 2018

f)

 

Place of the transaction

 

 

London Stock Exchange, XLON

 

 

Enquiries:

 

MedaPhor Group plc

www.medaphor.com

Stuart Gall, CEO

Tel: +44 (0)29 2075 6534



Cenkos Securities

Tel:  +44 (0)20 7397 8900

Mark Connelly (Nominated Advisor)


Michael Johnson / Julian Morse (Corporate Broking)




Walbrook PR

Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFSVIALTIIT
UK 100

Latest directors dealings